Skip to main content

KetoSwiss secures capital increase of 4 million dollars

| News

KetoSwiss secures capital increase of 4 million dollars


KetoSwiss has banked a total of 4 million US dollars from investors. The Basel-based startup develops products to alleviate neurological diseases such as migraines and brain ageing. KetoSwiss is now preparing to enter the US market in the first half of 2023 in addition to advancing clinical trials.

Our brain needs energy. KetoSwiss develops “brain fuels” (img: Screenshot of video from KetoSwiss)

KetoSwiss has raised a total of 4 million US dollars as part of a pre-Series A financing round. The Basel-based startup specializes in the area of brain metabolism and the role ketones play in this. With MigraKet, its first medical product under the Brain Ritual brand, KetoSwiss is seeking to support the fight against migraines.

Ketones or ketone bodies are the breakdown products of fat metabolism. If body cells do not receive enough glucose over a longer period of time, for example when starving or on a ketogenic diet, the body burns fat instead of glucose. The ketones produced in the kidneys can be used by the cells to meet their energy needs and heal inflammation.

Market launch in USA

According to an article on, KetoSwiss will use the fresh capital to prepare for the market launch of its Brain Ritual brand in the USA in the first half of 2023 and is expanding the US-based arm of the company. In addition, the startup is keen to achieve further R&D and clinical trial milestones. For example, the effects of MigraKet on brain function as well as on depression and other mental illnesses are to be examined.

The financing round was led by the North American William K. Karren Foundation, which supports research into neuropsychiatric disorders. Other investors involved include the venture capital firm R42 and the venture capital fund Healthspan Capital, both of which are based in the USA. They invest in biotechnology for longevity and regenerative medicine.

Basel Area Business & Innovation, the investment and innovation promotion agency, supported the startup via its Venture Mentoring program.

Share this article

Sign up to receive our newsletter in your inbox.

You may also be interested in

The power of a persuasive pitch deck

Are you an entrepreneur striving to secure investment for your biotech startup? Start with an effective pitch deck to catch...
Read More

Roche investing an additional 1.2 billion Swiss francs in Basel

Roche will be putting an additional 1.2 billion Swiss francs towards the renovation of its site in Basel. This investment...
Read More

Nouscom secures 67.5 million euros in financing

Biotech company Nouscom has raised 67.5 million euros in a series C financing round. The Basel-based firm intends to use...
Read More

Celebrating six months of innovation: i4Challenge accelerator New Ideas 2022/2023

On the 5th of July 2023, the 3rd iteration of the i4Challenge accelerator program New Ideas came to its conclusion....
Read More

How open innovation in healthtech hubs is fueling the rise of digital healthcare

How the ever-increasing uptake of digital solutions is enhancing patient engagement, increasing access to care and lowering the cost of...
Read More

How to access the U.S. market with your medical device

In one of our latest Venture Mentoring events by Basel Are Business & Innovation, we invited Nila-Pia Rähle to speak...
Read More

Do you have a question? We'd like to hear from you.